XETRDRW8
Market cap794mUSD
Dec 23, Last price
40.70EUR
1D
0.00%
1Q
-4.46%
Jan 2017
-37.56%
Name
Draegerwerk AG & Co KGaA
Chart & Performance
Profile
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as fire training facilities for firefighters. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 3,373,504 10.78% | 3,045,227 -8.51% | 3,328,419 -2.29% | |||||||
Cost of revenue | 3,194,858 | 3,126,863 | 3,050,122 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 178,646 | (81,636) | 278,297 | |||||||
NOPBT Margin | 5.30% | 8.36% | ||||||||
Operating Taxes | 29,327 | (38,772) | 82,377 | |||||||
Tax Rate | 16.42% | 29.60% | ||||||||
NOPAT | 149,319 | (42,864) | 195,920 | |||||||
Net income | 110,433 -273.54% | (63,637) -141.26% | 154,231 -18.22% | |||||||
Dividends | (3,681) | (3,681) | (4,048) | |||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (896) | (1,221) | (1,488) | |||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 131,801 | 119,580 | 78,195 | |||||||
Long-term debt | 460,624 | 358,537 | 391,918 | |||||||
Deferred revenue | 50,285 | 44,367 | 47,079 | |||||||
Other long-term liabilities | 271,342 | 279,433 | 660,540 | |||||||
Net debt | 278,515 | 144,128 | 16,510 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 189,677 | (144,228) | 384,886 | |||||||
CAPEX | (65,068) | (86,859) | (110,342) | |||||||
Cash from investing activities | (67,341) | 36,826 | (109,919) | |||||||
Cash from financing activities | (154,561) | (29,381) | (334,644) | |||||||
FCF | (104,042) | 32,044 | 90,052 | |||||||
Balance | ||||||||||
Cash | 279,357 | 306,671 | 572,159 | |||||||
Long term investments | 34,553 | 27,318 | (118,556) | |||||||
Excess cash | 145,235 | 181,728 | 287,182 | |||||||
Stockholders' equity | 1,102,201 | 1,119,759 | 1,001,705 | |||||||
Invested Capital | 2,055,340 | 1,729,603 | 1,928,292 | |||||||
ROIC | 7.89% | 10.32% | ||||||||
ROCE | 8.11% | 12.53% | ||||||||
EV | ||||||||||
Common stock shares outstanding | 18,760 | 18,760 | 18,760 | |||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | 178,646 | 62,815 | 427,604 | |||||||
EV/EBITDA | ||||||||||
Interest | 31,097 | 22,620 | 39,795 | |||||||
Interest/NOPBT | 17.41% | 14.30% |